Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

76.28
Delayed Data
As of 4:02pm ET
 -0.07 / -0.09%
Today’s Change
65.47
Today|||52-Week Range
99.14
-8.35%
Year-to-Date

Today’s Trading

Previous close76.35
Today’s open76.60
Day’s range75.94 - 77.01
Volume536,413
Average volume (3 months)1,662,294
Market cap$10.9B
Dividend yield0.84%
Data as of 4:02pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)-36,609.52%
Earnings growth (this year)-15.53%
Earnings growth (next 5 years)+5.85%
Revenue growth (last year)-4.71%
P/E ratio16.1
Price/Sales2.26
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+0.27+0.17%
ALKSAlkermes Plc-0.64-1.09%
SGENSeattle Genetics Inc-0.51-0.93%
ALNYAlnylam Pharmaceutic...-2.53-3.03%
Data as of 4:15pm ET, 07/25/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.92
Annual revenue (last year)$5.3B
Annual profit (last year)-$4.0B
Net profit margin-76.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer
Ron L. Winowiecki
Corporate headquarters
Dublin, Dublin

Forecasts